• Leahy, making sure that the government does not have to disclose any information under the Freedom of Information Act relating to drug inspections from a foreign government agency;
• Sen. Rob PortmanRob PortmanOvernight Healthcare: Watchdog says ObamaCare program made illegal payments Portman ad features father of fallen Iraq soldier Election-year politics: Senate Dems shun GOP vulnerables MORE (R-Ohio), directing the attorney general to establish uniform standards for the exchange of controlled substance and prescription information for the purpose of preventing diversion, fraud and abuse of controlled substances and other prescription drugs; and,
• Sen. Tom CoburnTom CoburnRyan calls out GOP in anti-poverty fight The Trail 2016: Words matter Ex-Sen. Coburn: I won’t challenge Trump, I’ll vote for him MORE (R-Okla.), to require an independent assessment of the FDA's review of drug applications.
Harkin also announced that another amendment from Coburn would be withdrawn — a proposal to require the Health and Human Services secretary to ensure that performance awards are connected to employee evaluations.
Senate Majority Leader Harry ReidHarry ReidThe missed opportunity of JASTA States urged to bolster election security How the White House got rolled on the Saudi-9/11 bill MORE (D-Nev.) said Thursday morning that he hoped some of the remaining 11 amendments to the FDA bill could be handled quickly. With the four unanimous consent votes, seven roll-call votes remain before final passage. These votes are scheduled for 2 p.m., but Reid said he hoped they might start earlier.